WeVote
Log In

Bill

Bill

S 637

Alzheimer's Disease

2025-2026 Regular Session Introduced by Tom Davis and 2 co-sponsors

S 637 - Alzheimer's Disease OverviewBill Number: S 637 Title: Alzheimer's Disease Status: Referred to Committee on Medical Affairs Introduced: February 19, 2025 Purpose and Inte

Referred to Committee on Medical Affairs
0
WeVote Research Nonpartisan
Bill Summary · S 637

S 637 - Alzheimer's Disease

Overview

Bill Number: S 637
Title: Alzheimer's Disease
Status: Referred to Committee on Medical Affairs
Introduced: February 19, 2025

Purpose and Intent

This bill aims to enhance research, treatment, and support for individuals living with Alzheimer's disease and their caregivers. The legislation recognizes Alzheimer's as a growing public health crisis that requires a comprehensive national strategy to address the medical, social, and economic impacts.

Key Provisions

  • Establishes the Alzheimer's Disease Center of Excellence to coordinate and expand federal research, clinical trials, and data collection on Alzheimer's
  • Increases funding for the National Institutes of Health (NIH) Alzheimer's disease research program by $500 million annually
  • Requires the Department of Health and Human Services (HHS) to develop a national plan to improve Alzheimer's prevention, diagnosis, care, and caregiver support
  • Expands Medicare coverage for early detection, diagnostic, and care planning services related to Alzheimer's
  • Provides grants to states to enhance home- and community-based services for Alzheimer's patients and their families

Affected Parties and Impacts

  • Individuals living with Alzheimer's disease would benefit from improved access to early detection, treatment, and support services
  • Caregivers for Alzheimer's patients would receive increased resources and respite care options
  • The medical research community would gain additional funding and coordination to advance Alzheimer's science and therapies
  • State and local governments would receive grants to strengthen their Alzheimer's care infrastructure and programs

Procedural and Timeline Considerations

S 637 has been referred to the Senate Committee on Medical Affairs for consideration. If reported favorably by the committee, the bill would then proceed to the full Senate for debate and a vote. Passage in the Senate would send the legislation to the House of Representatives for further action. The bill's prospects for enactment in the current Congress remain uncertain, as it faces potential budgetary and political challenges.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.